| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/06/2006 | US20060073281 Polyethylene glycol diacrylate dispersion crosslinked by N-isopropylacrylamide in an emulsion forms microspheres; loading cytokines for drug delivery without deactivating; solvent-free;time-release agents; bioavailability; anticarcinogenic, -tumor agents; cytokine; tissue-targeted therapy |
| 04/06/2006 | US20060073225 Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory |
| 04/06/2006 | US20060073223 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 04/06/2006 | US20060073210 Nanoparticles for paracellular drug delivery |
| 04/06/2006 | US20060073209 Nanoparticles for targeting hepatoma cells |
| 04/06/2006 | US20060073208 Cosmetic neurotoxin compositions and methods |
| 04/06/2006 | US20060073207 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 04/06/2006 | US20060073206 Coating meltable substances and substance mixtures |
| 04/06/2006 | US20060073205 Controlled release granules comprising porous silica core |
| 04/06/2006 | US20060073204 Modified release oral pharmaceutical composition |
| 04/06/2006 | US20060073203 Dry polymer and lipid composition |
| 04/06/2006 | US20060073202 Dual component medicament delivery system |
| 04/06/2006 | US20060073201 Extended release formulation |
| 04/06/2006 | US20060073200 Lercanidipine capsules |
| 04/06/2006 | US20060073199 Surfactant systems for delivery of organic compounds |
| 04/06/2006 | US20060073198 Sustained release of antifectives |
| 04/06/2006 | US20060073197 Encapsulated transfer factor compositions and methods of use |
| 04/06/2006 | US20060073196 Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier |
| 04/06/2006 | US20060073195 Tissue including a volatile rhinological composition |
| 04/06/2006 | US20060073190 Sealed, edible film strip packets and methods of making and using them |
| 04/06/2006 | US20060073189 Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
| 04/06/2006 | US20060073188 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same |
| 04/06/2006 | US20060073184 Viscoelastic composition, methods of use and packaging device with anti-oxidant |
| 04/06/2006 | US20060073176 Water-soluble composition containing coenzyme q10 |
| 04/06/2006 | US20060073175 Methods and formulations for delivery of pharmacologically active agents |
| 04/06/2006 | US20060073174 Adherent and erodible film to treat a moist surface of a body tissue |
| 04/06/2006 | US20060073173 Large-scale manufacturing process for the production of pharmaceutical compositions |
| 04/06/2006 | US20060073172 Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
| 04/06/2006 | US20060073158 Methods and compositions comprising supramolecular constructs |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073105 Novel dry powder inhalation system for transpulmonary administration |
| 04/06/2006 | US20060073103 Controlled Dosage Aerosols With Lecithin As Surface-Active Agent |
| 04/06/2006 | US20060073102 Abuse-resistant opioid solid dosage form |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | US20060073087 Method and apparatus for the formation of particles |
| 04/06/2006 | DE102004048390A1 Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff New inhalation powders based on modified lactose mixtures as an adjuvant |
| 04/06/2006 | DE102004048389A1 Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa Modifying surfaces of lactose as an excipient for use in powdered inhalants |
| 04/06/2006 | CA2581816A1 Microcapsules comprising a methylxanthine and a corticosteroid |
| 04/06/2006 | CA2581775A1 Dihydropyrimidine microcapsule - formulations |
| 04/06/2006 | CA2581764A1 Minicapsule formulations |
| 04/06/2006 | CA2581635A1 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 04/06/2006 | CA2581575A1 Medicinal aerosol formulations and methods of synthesizing ingredients therefor |
| 04/06/2006 | CA2581209A1 Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks |
| 04/06/2006 | CA2580357A1 Non-adhesive elastic gelatin matrices |
| 04/06/2006 | CA2579471A1 Stabilization of alum-adjuvanted immunologically active agents |
| 04/06/2006 | CA2579297A1 Semi-solid delivery vehicle and pharmaceutical compositions |
| 04/06/2006 | CA2578356A1 A new class of surfactant-like materials |
| 04/05/2006 | EP1642924A1 Composite particle and process for producing the same |
| 04/05/2006 | EP1642593A1 Solid pharmaceutical preparation |
| 04/05/2006 | EP1642591A1 MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 04/05/2006 | EP1642584A1 External preparation for improving coital function |
| 04/05/2006 | EP1642582A1 Low dose entecavir formulation and use |
| 04/05/2006 | EP1642579A1 Phentanyl-containing adhesive patch for application to oral-cavity mucosa |
| 04/05/2006 | EP1642578A2 Fentanyl composition for nasal administration |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1642572A1 Porous drug matrices and methods of manufacture thereof |
| 04/05/2006 | EP1642571A2 Method for preparing submicron particle suspensions |
| 04/05/2006 | EP1641490A2 Modified calcium phosphate excipient |
| 04/05/2006 | EP1641486A1 Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 04/05/2006 | EP1641463A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase |
| 04/05/2006 | EP1641462A1 Enteric coated composition comprising prostaglandin analogs as chloride channel opener |
| 04/05/2006 | EP1641459A1 Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis |
| 04/05/2006 | EP1641442A1 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component |
| 04/05/2006 | EP1641441A2 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
| 04/05/2006 | EP1641440A1 Tablet comprising fluvastatin and carmellose calcium |
| 04/05/2006 | EP1641439A1 Tablets containing enrofloxacin and flavouring agents and/or flavours |
| 04/05/2006 | EP1641438A1 Process for the preparation of the amorphous form of a drug |
| 04/05/2006 | EP1641437A1 The solid dispersion of tacrolimus |
| 04/05/2006 | EP1641436A1 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 04/05/2006 | EP1641435A2 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 04/05/2006 | EP1641434A1 Pharmaceutical formulations for intranasal administration of protein comprising chitosan or a derivative thereof |
| 04/05/2006 | EP1641424A2 Programmed immune responses using a vaccination node |
| 04/05/2006 | EP1641421A2 Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
| 04/05/2006 | EP1572152A4 Liposomal analgesic formulation and use |
| 04/05/2006 | EP1524975B1 Improved transdermal delivery system for the administration of rotigotine |
| 04/05/2006 | EP1485084B1 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 04/05/2006 | EP1465636A4 Compositions and methods for enhancing corticosteriod delivery |
| 04/05/2006 | EP1409494B1 Stabilized derivatives of ascorbic acid -3- phosphate |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1349544B1 Adhesive label with fluidifying agents for natural airway secretions |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | EP1320355B1 System for delivering a tobramycin formulation |
| 04/05/2006 | EP1310517B1 Lactic acid polymer and process for producing the same |
| 04/05/2006 | EP1294359B1 Process for preparing and harvesting crystalline particles |
| 04/05/2006 | EP1289504B1 Neurotoxin implant |
| 04/05/2006 | EP1244667B1 Cyclohexene nucleic acids |
| 04/05/2006 | EP1235581B1 Use of ribose to prevent cramping and soreness in muscles |
| 04/05/2006 | EP1210104B1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 04/05/2006 | EP1107783B1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/05/2006 | EP1085901B1 Transdermal use of secretin for the treatment of autism |
| 04/05/2006 | EP1051162B1 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate |
| 04/05/2006 | EP1041976B1 Polyamide oligomers |
| 04/05/2006 | EP0965339B1 Tabletted nateglinide preparation |
| 04/05/2006 | EP0741564B1 Novel method of the manufacture of suppositories |
| 04/05/2006 | CN2768779Y Allergic rhinitis medical plaster |
| 04/05/2006 | CN2768679Y Hemostatic rhinobyon |
| 04/05/2006 | CN1756575A Active agent delivery device having composite members |
| 04/05/2006 | CN1756541A Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid |
| 04/05/2006 | CN1756539A Wound dressing |
| 04/05/2006 | CN1756538A Stable oral benzimidazole compositions and processes for their preparation |